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Using atosiban in uterine contractions of early
pregnancies after assisted reproductionTo the Editor,
We are interested in a randomized trial of oxytocin antag-
onist atosiban versus b-adrenergic agonists in the treatment
of spontaneous preterm labor in Taiwanese women re-
ported by Lin et al1 in the June 2009 issue of the Journal of
the Formosan Medical Association. In that study, atosiban
was showed to be an effective tocolytic drug without the
conventional cardiovascular side-effects. They enrolled the
cases from gestational age of 24e33 weeks. In Taiwan, 8354
assisted reproductive technology (ART) cycles were per-
formed in 2008, leading to 36.5% clinical pregnancies, but
only 27.1% live births. We noticed that the first- and
second-trimester bleeding was more prevalent in ART than
in spontaneous pregnancies. In a large series study in Bel-
gium,2 of 2450 clinical pregnancies (not biochemical or
ectopic), 772 presented with first-trimester bleeding
(31.5%), and ultimately 436 miscarried (56.5% of patients
with first-trimester bleeding). It is not uncommon to find
regular uterine contractions before 20 weeks. In a recent
meta-analysis,3 nifedipine is superior to b2-adrenergic-
receptor agonists and magnesium sulfate for tocolysis in
women with preterm labor (20e36 weeks), but it has been
assigned to pregnancy category C by the Food and Drug
Administration (FDA) so is not recommended before 20
weeks, or even in the first trimester. A recent report4
showed, even at very early pregnancy, atosiban can be
used to decrease the frequency of uterine contractions to
enhance success of pregnancy. For cases of early pregnancy
with vaginal bleeding, if uterine contractions are noted
either by ultrasound (in the first trimester) or on tocometer
(in the second trimester), what can we do in addition to
traditional bed rest and progesterone supplements? From
2004 to 2010, we treated 33 first-trimester pregnancies
with vaginal bleeding after ART with evident uterine
contractions using ritodrine and/or atosiban, and there was
no preterm delivery before 30 weeks. This seems to be0929-6646/$ - see front matter Copyright ª 2011, Elsevier Taiwan LLC
doi:10.1016/j.jfma.2011.11.016much better than was reported in the Belgian study, in
which abortion rates were 56.5%2. However, we may need
a larger, prospective randomized study to prove the
effectiveness of tocolysis in such high-risk cases of threat-
ened abortion.
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